A rapid, multiplexed kinase activity assay using 8-plex iTRAQ labeling, SPE, and MALDI-TOF/TOF MS
Synthesized peptide substrates have been used for in vitro phosphorylation using purified kinases or cell lysates. For screening assays, a direct readout and comparison among different experimental conditions without using an internal standard would be preferred. In this study, we developed a rapid,...
Saved in:
Published in | Analyst (London) Vol. 145; no. 3; pp. 992 - 1 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Royal Society of Chemistry
03.02.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Synthesized peptide substrates have been used for
in vitro
phosphorylation using purified kinases or cell lysates. For screening assays, a direct readout and comparison among different experimental conditions without using an internal standard would be preferred. In this study, we developed a rapid, quantitative measurement method of multikinase activity based on MALDI-TOF/TOF MS. We combined 8-plex iTRAQ-labeled peptide substrates, solid phase extraction (SPE), and a phosphorylated peptide purification plate to rapidly determine multikinase activity in cell lysates. To enable our platform to be applicable in insulin stimulation and cancer drug inhibition, a list of peptide substrates was designed. By labeling peptide substrates with 8-plex iTRAQ reagents, protein kinase activity in 8 samples could be directly compared using the mass tags on their fragmented ion spectra. The protein amount and incubation time for multikinase activity assays were optimized, and the effect of insulin stimulation and an inhibitory drug on the cellular protein kinase activity was evaluated.
Synthesized peptide substrates with iTRAQ labeling has been used for
in vitro
kinase assay using cell lysates and detected by MALDI TOF/TOF MS. |
---|---|
Bibliography: | 10.1039/c9an01810g Electronic supplementary information (ESI) available: Supplementary Fig. 1-5 and Table 1. See DOI ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0003-2654 1364-5528 |
DOI: | 10.1039/c9an01810g |